Yan Chen

This inventor holds 53 USPTO granted patents and 31 published patent applications and 26 EPO patents, primarily in Cancer Immunotherapy. Top assignees: X-Body, Inc., Bristol-Myers Squibb Compnay, Juno Therapeutics Gmbh. Active years: 2010-2026.

USPTO Granted Patents = 53 (Patent Applications = 31)

% Patents Active = 86.8

EPO Patents = 26 (Patent Applications = 43)

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 333(Granted Patents)

Forward Citations (Not Self Cited) = 289(Dec 10, 2025)

Location History:

Wallingford, CT (US) (2014 - 2022)
Lexington, MA (US) (2010 - 2023)
Yardley, PA (US) (2021 - 2023)
Seattle, WA (US) (2021 - 2024)

Company Filing History:

Bristol-Myers Squibb Compnay

patents

7 out of 77

Juno Therapeutics Gmbh

patents

4. 5 out of 45

Viiv Healthcare UK (No.5) Limited

Viiv Healthcare UK (No. 4) Limited

patents

7. 2 out of 618

Memorial Sloan Kettering Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptors

Combination Therapy

Antibody Screening

HR+ Breast Cancer

Triterpenoids

Binding Agents

Target Antigen Discovery

HIV Inhibitors

PDGF Receptor

Protein Screening

Phenotypic Screens

Bi-Specific Polypeptides

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674000 - ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19 (2026-07-07),

2. 12544380 - Combination therapy using ribociclib and an aromatase inhibitor for the treatment of HR+ breast cancer (2026-02-10),

3. 12544379 - Combination therapy using ribociclib and fulvestrant for the treatment of HR+ breast cancer (2026-02-10),

4. 12428486 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2025-09-30),

5. 11919970 - Antibodies and chimeric antigen receptors specific for ROR1 (2024-03-05),

6. 11827714 - Antibodies and chimeric antigen receptors specific for CD19 (2023-11-28),

7. 11814441 - Bi-specific antigen-binding polypeptides (2023-11-14),

8. 11718601 - Pyridinyl substituted oxoisoindoline compounds (2023-08-08),

9. 11629434 - Antibody screening methods (2023-04-18),

10. 11623961 - Antibodies and chimeric antigen receptors specific for B-cell maturation antigen (2023-04-11),

11. 11464790 - Triterpenoids with HIV maturation inhibitory activity (2022-10-11),

12. 11414784 - Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes (2022-08-16),

13. 11339388 - Methods and compositions for generation of binding agents against cell surface antigens (2022-05-24),

14. 11268090 - X-display complexes for protein screening methods (2022-03-08),

15. 11166959 - Isofuranone compounds useful as HPK1 inhibitors (2021-11-09),

Title: Inventor Yan Chen - Pioneering Innovations in Lexington, MA

Introduction: Yan Chen is a visionary inventor based in Lexington, MA, known for her groundbreaking contributions to various technological fields.

Latest Patents: Yan Chen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in research and development, Yan Chen has led numerous successful projects that have resulted in cutting-edge inventions with real-world applications.

Collaborations: Throughout her career, Yan Chen has collaborated with top research institutions, leading companies, and universities, fostering a culture of innovation and knowledge-sharing.

Conclusion: Yan Chen's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.